The pioneer of Polyscientific Ayurveda discussed the vast potential of traditional medicine on an international stage
London: On October 7, Dr Ravishankar Polisetty, the pioneer of Polyscientific Ayurveda (PSA), gave a detailed presentation at the UK Parliament’s House of Commons about the expansive potential of traditional Ayurveda in global healthcare systems. Dr Polisetty was one of the key speakers at the ‘UK India Leaders Conference 2024,’ which is the 32nd summit to be held in the UK by the Europe-India Centre for Business and Industry (EICBI).
In his speech, Dr Polisetty also highlighted the potential for more partnerships between India, the UK, and other European nations in emerging fields like PSA, which merges Ayurveda with modern science. He noted that such collaborations would not only strengthen trade relations between India and these countries but also help EU nations reduce their significant annual healthcare costs, particularly in geriatric care.
He also discussed the nuances of the Free Trade Agreement and how it could benefit both India and the UK. “India could expand its exports of Ayurvedic products to the UK, while the UK could leverage advancements in intellectual property. This collaboration could lead to breakthroughs in elderly care and the management of end-stage diseases. Joint research initiatives in the UK would also generate valuable intellectual property, benefiting both nations,” said Dr Polisetty.
Recent studies like ‘The Fiscal Cost of Aging in Belgium – Pensions and Healthcare’ have revealed that palliative care alone requires substantial resources, costing close to 9,000 euros per day per individual, amounting to approximately 700 billion euros across the EU. Dr Polisetty, also the Founder and CEO of Sai Ganga Panakeia, said modern technology has helped his team develop groundbreaking wearables like Docture-Poly™ which could provide personalised care solutions to those who need it the most.
“There is, of course, a correlation between modern molecular biochemistry and traditional medicine. Their integration will not only help in developing more path-breaking devices like Docture-Poly™, but will also reduce costs, alleviate the disease burden, and improve health outcomes in European nations. Moreover, new collaborations can strengthen trade relations between India, the UK, and other European nations, promoting the exchange of knowledge and expertise,” added Dr Polisetty.
Lord Kulveer Singh Ranger, Baron Ranger of Northwood, emphasized the importance of continuing discussions with Dr. Polisetty, highlighting the value of deepening collaboration. He further noted that this could significantly position PSA as a leading global player in delivering integrative healthcare services.
In his address Dr Polisetty also presented a compelling case, highlighting how the integration of Poly Scientific Ayurveda could address critical challenges faced by The National Health Service, UK’s publicly funded healthcare system. Dr. Polisetty emphasized that PSA solutions had the potential to save the NHS GBP 100 billion in healthcare costs and GBP 256 billion in productivity losses annually.These pivotal insights underscore the potential of Poly Scientific Ayurveda to drive meaningful reform within the NHS, addressing both financial and operational challenges.
The key speakers at the summit included Lord Sahota, Member of the House of Lords, UK Parliament; Virendra Sharma, former Member of Parliament, United Kingdom; Olinga Taeed, Director of the Centre for Citizenship, Enterprise and Governance; Lars Berg, former Member of the European Parliament; and Andrew Rice, Chief Operating Officer of Global NRG Advisory Limited, along with other notable Members of Parliament, dignitaries, business leaders, and global influencers.
